🔎 Trials Near Me

Pradžia › Lėtinė inkstų liga › Ohio

Lėtinė inkstų liga klinikiniai tyrimai Ohio

15 tyrimai dėl Lėtinė inkstų liga ieško dalyvių vietose Ohio.

Miestai Ohio

Oficialus tyrimo tekstas (anglų kalba)

A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)

  • Investigator Site #20, Cleveland
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-10-01 · NCT07268638

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

  • Velocity Clinical Research, Cincinnati, Springdale, Cincinnati
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-30 · NCT07783802

A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure

  • Research Site, Canton
  • Research Site, Cincinnati
  • Research Site, Cincinnati
  • ir dar 3
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-25 · NCT06742723

A Phase III Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With CKD Stage 3b and 4 (BalanceD-CKD)

  • Research Site, Cincinnati
  • Research Site, Cincinnati
Renkami dalyviai3 fazė
Amžius nuo 18 iki 99 · Visoms lytims · Atnaujinta 2026-09-24 · NCT07624305

Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Atrasentan in Pediatric Patients With Primary IgAN

  • Cincinnati Childrens Hospital MC, Cincinnati
Renkami dalyviai3 fazė
Amžius nuo 2 iki 18 · Visoms lytims · Atnaujinta 2026-09-21 · NCT07498335

A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids)

  • Cincinnati Children's Hospital Medical Center, Cincinnati
  • Cleveland Clinic, Cleveland
Renkami dalyviai3 fazė
Amžius nuo 2 iki 17 · Visoms lytims · Atnaujinta 2026-09-16 · NCT07107945

A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.

  • Research Site, Cincinnati
  • Research Site, Maumee
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-09 · NCT07753993

Monocytes in Subjects With Type 1 Diabetes and Chronic Kidney Disease

  • Cleveland Clinic, Cleveland
Renkami dalyviaiStebimasis tyrimas
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-07-08 · NCT06694558

BZLF1 Peptide Vaccine (OSU-2131) With QS-21 for the Prevention of Epstein-Barr Virus Related Cancer in Patients Awaiting Solid Organ Transplants

  • Ohio State University Comprehensive Cancer Center, Columbus
Renkami dalyviai1 fazėLaukiami sveiki savanoriai
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-07-02 · NCT06741072

Ferric Citrate and Chronic Kidney Disease in Children

  • Cincinnati Children's Hospital Medical Center, Cincinnati
  • Nationwide Children's, Columbus
Renkami dalyviai2 fazė
Amžius nuo 6 iki 18 · Visoms lytims · Atnaujinta 2026-04-17 · NCT04741646

A Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmacokinetics of Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects With Chronic Kidney Disease (CKD)

  • Akron Nephrology Associates, Inc., Akron
Renkami dalyviai3 fazė
Amžius nuo 2 iki 17 · Visoms lytims · Atnaujinta 2026-04-17 · NCT03619850

Kidney Precision Medicine Project

  • Cleveland Clinic, Cleveland
Renkami dalyviaiStebimasis tyrimas
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-04-14 · NCT04334707

A Trial of Etelcalcetide in Pediatric Participants With Secondary Hyperparathyroidism and Chronic Kidney Disease on Hemodialysis

  • Cleveland Clinic Foundation, Cleveland
Renkami dalyviai3 fazė
Amžius nuo 0 iki 18 · Visoms lytims · Atnaujinta 2026-02-27 · NCT03633708

Transformative Research in Diabetic Nephropathy

  • Ohio State University, Columbus
Renkami dalyviaiStebimasis tyrimas
Amžius nuo 18 iki 100 · Visoms lytims · Atnaujinta 2026-02-27 · NCT02986984

A Study of a Novel Iron-based Phosphate Binder AP301 in Patients With Hyperphosphatemia in the U.S. and China

  • US Renal Care - Alexis, Toledo
Renkami dalyviai3 fazė
Amžius 12 ir vyresni · Visoms lytims · Atnaujinta 2026-01-29 · NCT06933472

Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.